Curis (CRIS) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Curis Revenue Highlights


Latest Revenue (Y)

$10.02M

Latest Revenue (Q)

$2.55M

Main Segment (Y)

Gross Royalty Revenue

Curis Revenue by Period


Curis Revenue by Year

DateRevenueChange
2023-12-31$10.02M-1.37%
2022-12-31$10.16M-4.57%
2021-12-31$10.65M-1.72%
2020-12-31$10.84M8.31%
2019-12-31$10.00M-4.07%
2018-12-31$10.43M5.35%
2017-12-31$9.90M31.50%
2016-12-31$7.53M-4.46%
2015-12-31$7.88M-19.96%
2014-12-31$9.84M-34.39%
2013-12-31$15.00M-11.61%
2012-12-31$16.97M14.97%
2011-12-31$14.76M-7.73%
2010-12-31$16.00M86.26%
2009-12-31$8.59M2.67%
2008-12-31$8.37M-48.95%
2007-12-31$16.39M9.73%
2006-12-31$14.94M148.83%
2005-12-31$6.00M21.20%
2004-12-31$4.95M-55.17%
2003-12-31$11.05M-39.92%
2002-12-31$18.39M1592.64%
2001-12-31$1.09M8.97%
2000-12-31$997.08K-68.96%
1999-12-31$3.21M-

Curis generated $10.02M in revenue during NA 2023, up -1.37% compared to the previous quarter, and up 96.12% compared to the same period a year ago.

Curis Revenue by Quarter

DateRevenueChange
2024-06-30$2.55M22.05%
2024-03-31$2.09M-22.63%
2023-12-31$2.70M-4.84%
2023-09-30$2.83M28.95%
2023-06-30$2.20M-4.35%
2023-03-31$2.30M-20.44%
2022-12-31$2.89M2.19%
2022-09-30$2.83M18.05%
2022-06-30$2.39M16.33%
2022-03-31$2.06M-34.39%
2021-12-31$3.13M3.16%
2021-09-30$3.04M32.94%
2021-06-30$2.29M4.43%
2021-03-31$2.19M-27.61%
2020-12-31$3.02M10.28%
2020-09-30$2.74M16.19%
2020-06-30$2.36M-12.88%
2020-03-31$2.71M-17.58%
2019-12-31$3.29M15.09%
2019-09-30$2.86M36.39%
2019-06-30$2.09M18.51%
2019-03-31$1.77M-35.86%
2018-12-31$2.75M-3.23%
2018-09-30$2.85M20.74%
2018-06-30$2.36M-4.46%
2018-03-31$2.47M-24.34%
2017-12-31$3.26M33.47%
2017-09-30$2.44M18.58%
2017-06-30$2.06M-3.28%
2017-03-31$2.13M-9.78%
2016-12-31$2.36M34.28%
2016-09-30$1.76M4.70%
2016-06-30$1.68M-2.66%
2016-03-31$1.73M-17.52%
2015-12-31$2.09M2.33%
2015-09-30$2.04M-1.80%
2015-06-30$2.08M25.58%
2015-03-31$1.66M-16.78%
2014-12-31$1.99M12.91%
2014-09-30$1.76M-63.24%
2014-06-30$4.80M273.75%
2014-03-31$1.28M-15.71%
2013-12-31$1.52M-78.84%
2013-09-30$7.20M33.26%
2013-06-30$5.40M520.17%
2013-03-31$871.43K-48.33%
2012-12-31$1.69M191.89%
2012-09-30$577.76K-86.72%
2012-06-30$4.35M-57.98%
2012-03-31$10.36M-26.49%
2011-12-31$14.09M9476.44%
2011-09-30$147.12K-62.55%
2011-06-30$392.87K194.20%
2011-03-31$133.54K33.16%
2010-12-31$100.29K-96.91%
2010-09-30$3.24M3187.21%
2010-06-30$98.63K-99.21%
2010-03-31$12.56M628.34%
2009-12-31$1.72M125.30%
2009-09-30$765.31K1109.73%
2009-06-30$63.26K-98.95%
2009-03-31$6.04M94.46%
2008-12-31$3.10M3479.87%
2008-09-30$86.72K-97.21%
2008-06-30$3.11M50.31%
2008-03-31$2.07M-82.00%
2007-12-31$11.48M-

Curis generated $2.55M in revenue during Q2 2024, up 22.05% compared to the previous quarter, and up 110.84% compared to the same period a year ago.

Curis Revenue Breakdown


Curis Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Gross Royalty Revenue$9.90M$10.28M$10.40M--
Other Revenue--$1.00K$214.00K-
Contra Revenue-$-116.00K$-101.00K$-103.00K-
Royalty--$10.75M$10.72M-
Research And Development, Net----$100.00K

Curis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Gross Royalty Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19Dec 18
Gross Royalty Revenue$2.60M$2.70M$2.30M$2.30M$2.90M$2.84M$2.47M$2.06M$3.10M$3.06M$2.35M$2.19M$2.72M$2.45M$2.52M$2.91M$2.14M$2.14M$2.80M-
Contra Revenue----$-14.00K$-18.00K$-81.00K$-3.00K$-19.00K$-63.00K$2.00K$-22.00K$22.00K$-86.00K$-17.00K$-50.00K$-48.00K$-370.00K--
Other Revenue--------$1.00K-$3.00K--$211.00K------

Curis's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Gross Royalty Revenue (100.00%).

Curis Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ADAPAdaptimmune Therapeutics$60.28M$128.23M
PIRSPieris Pharmaceuticals$42.81M-
CRISCuris$10.02M$2.55M
MREOMereo BioPharma Group$10.00M-
AFMDAffimed$8.28M$155.00K
CRVSCorvus Pharmaceuticals--
APTOAptose Biosciences--
XFORX4 Pharmaceuticals-$560.00K
PDSBPDS Bio--
DAWNDay One Biopharmaceuticals-$20.07M
INZYInozyme Pharma--
LPTXLeap Therapeutics--
ALRNAileron Therapeutics--
TERNTerns Pharmaceuticals--
ARTLArtelo Biosciences--

CRIS Revenue FAQ


What is Curis’s yearly revenue?

Curis's yearly revenue for 2023 was $10.02M, representing a decrease of -1.37% compared to 2022. The company's yearly revenue for 2022 was $10.16M, representing a decrease of -4.57% compared to 2021. CRIS's yearly revenue for 2021 was $10.65M, representing a decrease of -1.72% compared to 2020.

What is Curis’s quarterly revenue?

Curis's quarterly revenue for Q2 2024 was $2.55M, a 22.05% increase from the previous quarter (Q1 2024), and a 15.89% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.09M, a -22.63% decrease from the previous quarter (Q4 2023), and a -9.19% decrease year-over-year (Q1 2023). CRIS's quarterly revenue for Q4 2023 was $2.7M, a -4.84% decrease from the previous quarter (Q3 2023), and a -6.62% decrease year-over-year (Q4 2022).

What is Curis’s revenue growth rate?

Curis's revenue growth rate for the last 3 years (2021-2023) was -5.88%, and for the last 5 years (2019-2023) was 0.19%.

What are Curis’s revenue streams?

Curis's revenue streams in c 23 are Gross Royalty Revenue

What is Curis’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Curis was Gross Royalty Revenue. This segment made a revenue of $9.9M, representing 100.00% of the company's total revenue.